Skip to main content
. 2023 May 12;10:1192762. doi: 10.3389/fmed.2023.1192762

Figure 4.

Figure 4

Subgroup meta-analysis comparting the overall survival grouped by studies that used different ICPI agents. Abbreviations: ATZ: Atezolizumab; AVE: Avelumab; NIV: Nivolumab; PMB: Pembrolizumab.